WFU

2021年7月4日 星期日

兩年階段回顧

 

從107/11/23 兼任主管職(跳火坑),工作從每周門診住院照顧﹑值班﹑急診照會﹑病房照會暴增各種行政雜事(但是非公務員沒行政加給)。要感謝前林院長唐主任努力打下的基礎和團隊夥伴的幫忙。


科部團隊

開啟營運兩個慢性病房,急慢性病床從30床到144床

107/Q3平均每月營收4,261,124到 110/04的 8,343,855(成長234.7%)

(小科相當年營收近億的小企業) 

團隊(醫社心職專師成癮)從20人成長到26人

108通過醫院評鑑

109協助成立憂鬱症中心


個人專業

專注腦刺激治療(Brain stimulation)

歐盟經顱磁刺激(TMS)證書

美國臨床經顱磁刺激(TMS)會員

累積發表腦刺激相關研究SCI論文10篇

109/11感謝院長蘇副引進Apollo TMS,已治療超過300人次,110/05首次完成困難個案住院TMS治療(外縣市轉介)

引進新一代HRV進行治療前後生物標記評估

引進CES微電流刺激提供可攜式腦刺激治療



研究教學

109/6 中國醫藥大學臨床醫學博士

109/9 中國醫藥大學專任助理教授

來安南醫院後持續發表10篇,累積論文36篇

2021 台灣台北(2020疫情延後)舉行 32th International College of Neuropsychopharmacology (CINP) World Congress of Neuropsychopharmacology 獲獎 「Student Encouragement Award」
2020 台灣精神醫學會59週年年會暨學術研討會優良壁報獎。身心介面國際研討會(MBI) Poster Blitz Awardees
2019身心介面國際研討會Mind-Body Interface (MBI) International Symposium Best Poster Award

Hepatitis C virus and hepatitis B virus in patients with schizophrenia

CH Chang, CY Liu, SJ Chen, HC Tsai

Medicine 100 (22) 2021

Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer’s disease: Machine learning approaches

CH Chang, CH Lin, CY Liu, CS Huang, SJ Chen, WC Lin, HT Yang, ...

Journal of Psychopharmacology 35 (3), 265-272 1 2021

中文版 [思考-語言障礙量表] 於思覺失調症病患之信度與效度探究

鄭博之, 張俊鴻, 陳紹基, 劉介宇

台灣醫學 25 (1), 24-35 2021

Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease

CH Chang, CH Lin, HY Lane

International Journal of Molecular Sciences 22 (5), 2761 2021

Cerebrospinal fluid and serum D-serine levels in patients with Alzheimer’s disease: A systematic review and meta-analysis

CH Chang, HL Kuo, WF Ma, HC Tsai

Journal of Clinical Medicine 9 (12), 3840 1 2020

Changes in telepsychiatry regulations during the COVID-19 pandemic: 17 countries and regions' approaches to an evolving healthcare landscape

S Kinoshita, K Cortright, A Crawford, Y Mizuno, K Yoshida, D Hilty, ...

Psychological medicine, 1-8 9 2020

Efficacy and cognitive effect of sarcosine (N-methylglycine) in patients with schizophrenia: a systematic review and meta-analysis of double-blind randomised controlled trials

CH Chang, CH Lin, CY Liu, SJ Chen, HY Lane

Journal of Psychopharmacology 34 (5), 495-505 8 2020

d-glutamate and Gut Microbiota in Alzheimer’s Disease

CH Chang, CH Lin, HY Lane

International journal of molecular sciences 21 (8), 2676 24 2020

Paliperidone is associated with reduced risk of severe hepatic outcome in patients with schizophrenia and viral hepatitis: a nationwide population-based cohort study

CH Chang, HY Lane, CY Liu, SJ Chen, CH Lin

Psychiatry research 281, 112597 2 2019

Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised …

CH Chang, HY Lane, PT Tseng, SJ Chen, CY Liu, CH Lin

Journal of Psychopharmacology 33 (4), 436-448 13 2019

C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia

CH Chang, HY Lane, CY Liu, PC Cheng, SJ Chen, CH Lin

Neuropsychiatric disease and treatment 15, 2621, 2019